The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been approved by the U.S. Food & Drug Administration (FDA), or any other…
- Investigator
- Joanne Lagmay
- Ages
- N/A - 26 Years
- Sexes
- All